参考文献/References:
[1] Moriya J.Critical roles of inflammation in atherosclerosis[J].J Cardiol,2019,73(1):22-27.
[2] 冯 君,刘建和,冉俊宁,等.从痰、瘀、虚探讨动脉粥样硬化的中西医病机[J].陕西中医,2020,41(2):217-219.
[3] 陈博欣,汤雪纯,郝二伟.现代名中医治疗动脉粥样硬化的用药规律研究[J].中医临床研究,2017,9(27):31-34.
[4] 刘新叶,李 勇,杨东伟.盾叶冠心宁联合丹参酮治疗冠状动脉粥样硬化疗效及对患者左室功能的影响[J].陕西中医,2019,40(5):584-586.
[5] 赵桂峰,范英昌,郭茂娟.丹酚酸B对ApoE基因敲除糖尿病小鼠动脉粥样硬化的防治作用[J].中国老年学杂志,2013,33(4):858-859.
[6] 迟晓君,朱靖博,李梅松,等.丹酚酸B调节胆固醇代谢的研究[J].安徽农业科学,2011,39(8):4742,4746.
[7] Ren Y,Tao S,Zheng S,et al.Salvianolic acid B improves vascular endothelial function in diabetic rats with blood glucose fluctuations via suppression of endothelial cell apoptosis[J].Eur J Pharmacol,2016,791(1):308-315.
[8] Joe Y,Zheng M,Kim HJ,et al.Salvianolic acid B exerts vasoprotective effects through the modulation of heme oxygenase-1 and arginase activities[J].J Pharmacol Exp Ther,2012,341(3):850-858.
[9] Xu S,Zhong A,Bu X,et al.Salvianolic acid B inhibits platelets-mediated inflammatory response in vascular endothelial cells[J].Thromb Res,2015,135(1):137-145.
[10] Stumpf C,Fan Q,Hintermann C,et al.Anti-inflammatory effects of danshen on human vascular endothelial cells in culture[J].Am J Chin Med,2013,41(5):1065-1077.
[11] 郑 纺,姜希娟.丹酚酸B对糖尿病动脉粥样硬化Apo E基因敲除小鼠斑块面积及斑块内AGEs和RAGE表达的影响[J].天津医药,2010,38(9):777-780.
[12] 王 丽.丹酚酸B在巨噬细胞胆固醇外排中的作用[J].中国医药生物技术,2013,8(2):100-106.
[13] Ma Q,Yang Q,Chen J,et al.Salvianolic acid a ameliorates early-stage atherosclerosis development by inhibiting NLRP3 inflammasome activation in Zucker diabetic fatty rats[J].Molecules,2020,25(5):1089.
[14] Xiang Y,Ye S,Cai C,et al.Salvianolic acid a attenuates limb ischemia/reperfusion injury in skeletal muscle of rats[J].Biomed Pharmacother,2018,97:551-556.
[15] Song Q,Zhang Y,Han X,et al.Potential mechanisms underlying the protective effects of salvianic acid A against atherosclerosis in vivo and vitro[J].Biomed Pharmacother,2019,109:945-956.
[16] 王 蓉,王 静,宋复兴,等.丹参素通过调节Nrf2/HO-1和NF-κB/IκBα信号通路发挥抗大鼠肝纤维化的作用[J].中国药理学与毒理学杂志,2019,33(10):918.
[17] Gao H,Li L.Danshensu promotes cholesterol efflux in RAW264.7 macrophages[J].Lipids,2016,51(9):1083-1092.
[18] Wang J,Xu P,Xie X,et al.DBZ(Danshensu Bingpian Zhi),a novel natural compound derivative,attenuates atherosclerosis in apolipoprotein E-deficient mice[J].J Am Heart Assoc,2017,6(10):e6297.
[19] 赵秋宇,贾连群,王俊岩,等.丹参酮ⅡA对Apo E动脉粥样硬化小鼠腹腔巨噬细胞胆固醇流出相关基因表达的影响[J].中医药导报,2016,22(11):15-19,27.
[20] 唐 林,黎宗宝,白瑞娜.丹参酮ⅡA对氧化型低密度脂蛋白诱导血管内皮损伤的防护作用[J].中国药业,2020,29(5):63-66.
[21] 曹慧敏,宋 囡,张 妮,等.丹参酮ⅡA对EA.Hy926氧化应激细胞模型自噬的影响及其时效关系的研究[J].临床心血管病杂志,2017,33(2):183-187.
[22] 陈 萍,陈文娜.丹参酮ⅡA通过调控巨噬细胞极化抗动脉粥样硬化的机制研究[J].辽宁医学杂志,2019,33(6):70-74.
[23] Gao S,Wang Y,Li D,et al.TanshinoneIIA alleviates inflammatory response and directs macrophage polarization in lipopolysaccharide-stimulated RAW264.7 cells[J].Inflammation,2019,42(1):264-275.
[24] Chen W,Li X,Guo S,et al.Tanshinone IIA harmonizes the crosstalk of autophagy and polarization in macrophages via miR-375/KLF4 pathway to attenuate atherosclerosis[J].Int Immunopharmacol,2019,70:486-497.
[25] 付 鑫,卢 杰,李 潞,等.丹参酮ⅡA对ApoE基因敲除动脉粥样硬化小鼠主动脉TNF-α/p38MAPK/NF-κB/RBP4信号通路变化研究[J].辽宁中医药大学学报,2018,20(1):18-21.
[26] 陈 卓.从TLR4/MyD88/NF-κB通路探讨丹参酮ⅡA干预动脉粥样硬化易损斑块的抗炎及免疫调节机制[D].北京:北京中医药大学,2016.
[27] Liu Z,Xu S,Huang X,et al.Cryptotanshinone,an orally bioactive herbal compound from Danshen,attenuates atherosclerosis in apolipoprotein E-deficient mice:Role of lectin-like oxidized LDL receptor-1(LOX-1)[J].Br J Pharmacol,2015,172(23):5661-5675.
[28] 李春霞.二氢丹参酮Ⅰ预防实验性动脉粥样硬化作用的初步研究[D].遵义:遵义医学院,2017.
[29] Zhao W,Li C,Gao H,et al.Dihydrotanshinone I attenuates atherosclerosis in ApoE-/- deficient mice:Role of NOX4/NF-κB mediated lectin-like oxidized LDL receptor-1(LOX-1)of the endothelium[J].Front Pharmacol,2016,7:418.
相似文献/References:
[1]王清亮,陆文杰,陈咸川.益气活血化痰通络方对颈动脉粥样硬化患者T细胞亚群影响的研究[J].陕西中医,2019,(3):307.
WANG Qingliang,LU Wenjie,CHEN Xianchuan..Effect of Yiqi Huoxue Huatan Tongluo formula on Tcells subset in patients with carotid atherosclerosis[J].,2019,(7):307.
[2]陈 静,陈 炜,伍 媛,等.小续命汤及其组分治疗急性脑梗死研究进展*[J].陕西中医,2019,(12):1818.
[3]冯 君,刘建和,冉俊宁,等.从痰、瘀、虚探讨动脉粥样硬化的中西医病机*[J].陕西中医,2020,(2):217.
FENG Jun,LIU Jianhe,RAN Junning,et al.Discussion on the pathogenesis of atherosclerosis from phlegm,blood stasis and asthenia[J].,2020,(7):217.
[4]陈雨菡,马善波,杨 倩,等.黄芪-丹参药对治疗缺血性脑卒中研究进展[J].陕西中医,2021,(8):1142.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.038]
CHEN Yuhan,MA Shanbo,YANG Qian,et al.Therapeutic effect of Astragali-Salvia miltiorrhiza for ischemic stroke[J].,2021,(7):1142.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.038]
[5]蔡 婉,周 华,葛 文,等.清脂化瘀颗粒调控Keap-1/Nrf2/ARE介导的氧化损伤抗动脉粥样硬化的作用及机制研究[J].陕西中医,2022,(2):166.[doi:DOI:10.3969/j.issn.1000-7369.2022.02.006]
CAI Wan,ZHOU Hua,GE Wen,et al.Effect and mechanism of Qingzhi Huayu granule on regulating Keap-1/Nrf2/ARE mediated oxidative damage and anti atherosclerosis[J].,2022,(7):166.[doi:DOI:10.3969/j.issn.1000-7369.2022.02.006]
[6]周丽娜,辛 欢,杨 敏,等.丹参酚酸A对脑缺血大鼠神经功能及热休克蛋白基因表达的影响[J].陕西中医,2022,(11):1521.[doi:DOI:10.3969/j.issn.1000-7369.2022.11.007]
ZHOU Lina,XIN Huan,YANG Min,et al.Effects of salvianolic acid A on nerve function and heat shock protein gene expression in rats with cerebral ischemia[J].,2022,(7):1521.[doi:DOI:10.3969/j.issn.1000-7369.2022.11.007]
[7]陈抒鹏,王思梦,唐娜娜,等.基于浊邪与铁死亡相关性探析动脉粥样硬化之病机[J].陕西中医,2022,(11):1589.[doi:DOI:10.3969/j.issn.1000-7369.2022.11.023]
CHEN Shupeng,WANG Simeng,TANG Nana,et al.Exploring the pathogenesis of atherosclerosis based on the correlation between turbid pathogens and ferroptosis[J].,2022,(7):1589.[doi:DOI:10.3969/j.issn.1000-7369.2022.11.023]
[8]Nguyen Xuan Huynh(越南),梁 硕,孟 毅,等.益气活血清热解毒方治疗动脉粥样硬化临床研究[J].陕西中医,2023,(6):746.[doi:DOI:10.3969/j.issn.1000-7369.2023.06.014]
Nguyen Xuan Huynh,LIANG Shuo,MENG Yi,et al.Clinical study of Yiqi Huoxue Qingre Jiedu recipe in the treatment of atherosclerosis[J].,2023,(7):746.[doi:DOI:10.3969/j.issn.1000-7369.2023.06.014]
[9]黄昌锐,李汶珊,袁 惠,等.护心康片对动脉粥样硬化小鼠自噬干预机制[J].陕西中医,2023,(7):854.[doi:DOI:10.3969/j.issn.1000-7369.2023.07.006]
HUANG Changrui,LI Wenshan,YUAN Hui,et al.Intervention mechanism of cardiac protection tablets on autophagy in atherosclerotic mice[J].,2023,(7):854.[doi:DOI:10.3969/j.issn.1000-7369.2023.07.006]
[10]陈 姣,罗丹梅,孙承霞,等.扶正化浊法治疗动脉粥样硬化研究进展[J].陕西中医,2023,(11):1653.[doi:DOI:10.3969/j.issn.1000-7369.2023.11.039]
CHEN Jiao,LUO Danmei,SUN Chengxia,et al.Research progress of atherosclerosis based on Fuzheng Huazhuo treatment[J].,2023,(7):1653.[doi:DOI:10.3969/j.issn.1000-7369.2023.11.039]